Inhibrx Biosciences Inc (INBX)

Operating Expenses

$32.15M

Quarterly · Period ending: · USD

INBX logo

INBX Operating Expenses

Latest reported$32.15M
INBX Quarterly Operating Expenses ($880.00K → $32.15M)
High-resolution chart · PNG

INBX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibrx Biosciences Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
32,149,000
30,390,000
30,359,000
33,230,000
28,027,000
42,226,000
49,339,000
46,037,000
160,998,000
73,465,000
89,625,000
45,642,000
41,074,000
43,489,000
35,054,000
29,562,000
34,600,000
29,247,000
21,568,000
20,657,000
20,755,000
2,992,999
19,883,000
21,384,000
20,501,000
18,483,000
16,721,000
5,027,000
1,631,999
1,455,000
1,657,000
977,000
883,000
880,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.